President Barack Obama is making a fresh attempt to rescue his health care overhaul by proposing a measure that would allow
the government to deny or roll back egregious insurance premium increases that infuriate consumers.
At the heart of the debate is the question of what should be a fair profit for health insurers. WellPoint CEO Angela Braly
will likely be grilled on the issue when she appears at a Congressional hearing Wednesday.
President Obama will release a proposal to restart the health-care debate before a bipartisan White House meeting on Feb.
25, one day after WellPoint officials testify before Congress about steep rate increases.
Evista generated $1.03 billion in sales last year, of which $348.1 million came outside the United States.
Eli Lilly and Co. directors have recommended that shareholders toss out the
drugmaker's most potent protection against unwanted takeovers: an 80-percent supermajority vote threshold for any shareholder
mutiny to succeed.
The furor over WellPoint Inc.’s premium hikes have migrated from California to Indiana, where state lawmakers held a
high-profile hearing.
The firms continued to grow over the last year but face increasing challenges, according to a new report by Indianapolis-based
life sciences trade group BioCrossroads.
Indianapolis-based Vortek Surgical LLC will relocate to Brownsburg, expanding its headquarters, manufacturing and distribution
operations and creating more than 60 jobs in the next three years.
Nationwide report ranks Marion County 87th out of 92 Indiana counties in health factors and 80th in health outcomes.
Congressman Andre Carson will make remarks Thursday during a public chastising of Indianapolis-based health insurer for 21-percent rate
hike on individuals.
State House insurance committee chair grills executives about WellPoint’s 21-percent premium increase for individual policyholders
in Indiana.
Arkansas Attorney General Dustin McDaniel on Tuesday announced an $18.5 million settlement of a lawsuit with Eli Lilly &
Co. over off-label marketing of the anti-psychotic drug Zyprexa.
Three WellPoint executives will be on hand Wednesday morning to answer questions about premium increases on its individual
policies, which have risen as high as 39 percent this year.
The patent on impotence drug Viagra was partially rejected after the U.S. Patent and Trademark Office said it wasn’t different
enough from a Chinese herb known as Horny Goat Weed. The patent was key to an infringement suit Pfizer filed in 2002 against
Eli Lilly and Co. over its rival Cialis drug.
Stimulus funds will help university’s technical assistance service show doctors and nurses in small groups and in medically under-served areas how to adopt medical-records technologies.
The Indianapolis-based insurer, preparing for Congressional testimony on proposed premium increases in California, says its
earnings forecast is now less clear.
Even before WellPoint dissatisfied President Obama over its rate increases in California, it wasn’t doing so hot satisfying
its actual customers, according to the American Customer Satisfaction Index.
The Indiana Clinic, launched about a year ago, has signed 412 physicians as employees, and is still working
toward a goal of as many as 1,500 by 2011. The clinic, a joint venture of Clarian Health and the Indiana University
School of Medicine, is headed by Dr. John Fitzgerald. He discussed the progress.
Marian University’s planned medical school is one of two dozen nationally, but budget cuts are forcing Indiana University to retreat
on enrollment expansion.
The firestorm created this week by Indianapolis-based health insurer WellPoint’s spike in premiums could resurrect some parts
of
the languishing health reform bills.
